v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive (Loss) Income
Treasury Stock
Common Stock
Beginning balance (in shares) at Dec. 31, 2024   19,796,519          
Beginning balance at Dec. 31, 2024 $ 655,018 $ 19,797 $ 480,491 $ 181,597 $ (16,825) $ (10,042)  
Net income 13,742     13,742      
Total other comprehensive income (loss) 2,662       2,662    
Common stock cash dividends declared, $0.22 per share (3,870)     (3,870)      
Repurchased stock 0         0  
Employee Stock Purchase Plan (in shares)   5,311          
Employee Stock Purchase Plan 137 $ 5 132        
Director Stock Purchase Plan (in shares)   986          
Director Stock Purchase Plan 26 $ 1 25        
Restricted stock activity 218   218        
Ending balance (in shares) at Mar. 31, 2025   19,802,816          
Ending balance at Mar. 31, 2025 667,933 $ 19,803 480,866 191,469 (14,163) (10,042)  
Beginning balance (in shares) at Dec. 31, 2024   19,796,519          
Beginning balance at Dec. 31, 2024 655,018 $ 19,797 480,491 181,597 (16,825) (10,042)  
Net income 18,504            
Total other comprehensive income (loss) 5,069            
Ending balance (in shares) at Jun. 30, 2025   23,418,728          
Ending balance at Jun. 30, 2025 775,708 $ 23,419 584,291 191,574 (11,756) (11,820)  
Beginning balance (in shares) at Mar. 31, 2025   19,802,816          
Beginning balance at Mar. 31, 2025 667,933 $ 19,803 480,866 191,469 (14,163) (10,042)  
Net income 4,762     4,762      
Total other comprehensive income (loss) 2,407       2,407    
Common stock cash dividends declared, $0.22 per share (4,657)     (4,657)      
Common stock issued in business combination (in shares) [1]   3,506,795          
Common stock issued in business combination [1] 103,206 $ 3,507 99,699        
Stock options exercised (in shares)   31,323          
Stock options exercised 3,364 $ 31 3,333        
Repurchased stock (1,778)         (1,778)  
Employee Stock Purchase Plan (in shares)   4,636          
Employee Stock Purchase Plan 120 $ 5 115        
Director Stock Purchase Plan (in shares)   901          
Director Stock Purchase Plan 25 $ 1 24        
Restricted stock activity (in shares)   72,257          
Restricted stock activity 326   254       $ 72
Ending balance (in shares) at Jun. 30, 2025   23,418,728          
Ending balance at Jun. 30, 2025 $ 775,708 $ 23,419 584,291 191,574 (11,756) (11,820)  
Beginning balance (in shares) at Dec. 31, 2025 23,047,203 23,567,094          
Beginning balance at Dec. 31, 2025 $ 814,058 $ 23,567 589,421 219,685 (6,323) (12,292)  
Net income 8,706     8,706      
Total other comprehensive income (loss) (1,834)       (1,834)    
Common stock cash dividends declared, $0.22 per share (6,237)     (6,237)      
Common stock issued in business combination (in shares) [2]   2,238,085          
Common stock issued in business combination [2] 71,853 $ 2,238 69,615        
Stock options exercised 132   132        
Repurchased stock 0            
Employee Stock Purchase Plan (in shares)   5,352          
Employee Stock Purchase Plan 166 $ 5 161        
Director Stock Purchase Plan (in shares)   855          
Director Stock Purchase Plan 28 $ 1 27        
Restricted stock activity (in shares)   5,268          
Restricted stock activity 533 $ 6 527        
Ending balance (in shares) at Mar. 31, 2026   25,816,654          
Ending balance at Mar. 31, 2026 $ 887,405 $ 25,817 659,883 222,154 (8,157) (12,292)  
Beginning balance (in shares) at Dec. 31, 2025 23,047,203 23,567,094          
Beginning balance at Dec. 31, 2025 $ 814,058 $ 23,567 589,421 219,685 (6,323) (12,292)  
Net income 30,397            
Total other comprehensive income (loss) $ (2,819)            
Ending balance (in shares) at Jun. 30, 2026 25,320,686 25,923,997          
Ending balance at Jun. 30, 2026 $ 901,907 $ 25,924 661,903 238,224 (9,142) (15,002)  
Beginning balance (in shares) at Mar. 31, 2026   25,816,654          
Beginning balance at Mar. 31, 2026 887,405 $ 25,817 659,883 222,154 (8,157) (12,292)  
Net income 21,691     21,691      
Total other comprehensive income (loss) (985)       (985)    
Common stock cash dividends declared, $0.22 per share (5,621)     (5,621)      
Stock options exercised (in shares)   33,807          
Stock options exercised 1,076 $ 34 1,042        
Repurchased stock (2,710)         (2,710)  
Employee Stock Purchase Plan (in shares)   4,470          
Employee Stock Purchase Plan 143 $ 4 139        
Director Stock Purchase Plan (in shares)   791          
Director Stock Purchase Plan 28 $ 1 27        
Restricted stock activity (in shares)   68,275          
Restricted stock activity $ 880 $ 68 812        
Ending balance (in shares) at Jun. 30, 2026 25,320,686 25,923,997          
Ending balance at Jun. 30, 2026 $ 901,907 $ 25,924 $ 661,903 $ 238,224 $ (9,142) $ (15,002)  
[1] Shares issued on April 30, 2025 as a result of the William Penn acquisition. See "Note 2 - Business Combinations" to the Consolidated Financial Statements for more information.
[2] Shares issued on January 1, 2026 and February 27, 2026 as a result of the Cumberland Advisors and 1st Colonial acquisitions. See "Note 2 - Business Combinations" to the Consolidated Financial Statements for more information.